Stock Market Update - March 30, 2026
Today's stock market saw some significant movers. Here's a breakdown of 5 stocks that caught our attention:
1. OP - OceanPal Inc.
Price: $7.46 | Change: +2030.82% ($7.1099)
OP:NASDAQ (now trading as SVRN) experienced a staggering 2030.82% gain around March 31, 2026. This dramatic price increase was primarily a result of a 1-for-20 reverse stock split that took effect on March 30, 2026. This corporate action significantly reduced the total number of outstanding shares, effectively increasing the price per share to help the company comply with Nasdaq's minimum bid price requirement.
Beyond this significant share consolidation, OceanPal also revealed a strategic pivot. The company is diving into digital asset management through its new subsidiary, SovereignAI Services LLC, acquiring millions of NEAR tokens to generate staking rewards. They are projecting positive earnings in 2026 from both their existing shipping business and this new digital asset venture.
What makes SVRN particularly noteworthy is this dual transformation: not only did it undergo a major restructuring with the reverse split, but it's also making a bold move into the rapidly evolving digital asset space, aiming for a fresh start.
2. ELAB - PMGC Holdings Inc.
Price: $3.56 | Change: +113.17% ($1.89)
ELAB:NASDAQ recently saw an impressive 113.17% gain around late March 2026, drawing significant attention. This surge was primarily fueled by a series of positive corporate developments announced by PMGC Holdings Inc., the company behind the ticker.
A major catalyst was their Annual Report, which showcased a substantial 43% increase in total assets, largely attributed to strategic acquisitions made during 2025 in precision manufacturing and industrial packaging. Adding to this positive momentum, PMGC’s subsidiary, SVM Machining, achieved ITAR compliance, enabling it to pursue new opportunities within the U.S. defense manufacturing sector. Another subsidiary, NorthStrive Biosciences, also streamlined a key licensing agreement, potentially accelerating clinical trials for its muscle preservation therapies.
These combined announcements highlighted a period of strong growth and strategic expansion across PMGC Holdings' diverse portfolio, ranging from advanced manufacturing to defense and biotechnology. The market clearly reacted with enthusiasm to these developments.
3. ITRM - Iterum Therapeutics plc
Price: $0.0704 | Change: +97.75% ($0.0348)
ITRM just logged a striking 97.75% gain, a move that might seem counter-intuitive given the underlying news. Iterum Therapeutics plc recently filed a winding-up petition, initiating the process of provisional liquidation due to limited cash, an inability to raise more capital, and failing to secure a buyer for its main drug, sulopenem.
Despite these dire corporate circumstances, the stock experienced a dramatic surge, climbing over 140% on March 30, 2026. This unusual spike is largely attributed to speculative trading activity, often observed with distressed, low-priced biotech stocks.
What makes this particularly noteworthy is the market's reaction to a company facing dissolution: shares rocketed up. A court hearing for the winding-up petition is scheduled for April 13, 2026, which, if granted, will lead to the company's eventual dissolution and likely withdrawal of its product, ORLYNVAH, from the U.S. market.
4. ASTC - Astrotech Corporation
Price: $4.65 | Change: +96.20% ($2.28)
ASTC experienced a remarkable 96.20% gain around March 30-31, 2026. This significant surge wasn't fueled by a specific company announcement, but rather a powerful combination of market optimism, strong technical trading signals, and a perceived undervaluation of Astrotech Corporation's shares.
Interestingly, this jump occurred even though the company's recent financial reports showed challenges with decreased revenue and profitability. What likely reassured investors was Astrotech's robust liquidity position—meaning it had ample resources to cover short-term obligations—which provided a strong foundation despite operational concerns.
Technical indicators also played a key role, with signals like the RSI and Stochastic Oscillator suggesting a shift towards an upward trend, and a "buy" signal emerging from a pivot point just days before the climb. This movement showcases how perceived value, strong financial stability, and positive technical momentum can significantly impact a stock's performance, even without a major corporate news headline.
5. PMNT - Perfect Moment Ltd. Common Stock
Price: $0.325 | Change: +74.73% ($0.139)
PMNT saw an impressive 74.73% gain recently, thanks to a significant $12 million growth financing package. The luxury lifestyle brand, Perfect Moment Ltd., secured this capital on March 30, 2026. The package included a $10 million revolving credit facility and a $2 million equity investment, with the latter made at a notable 75% premium to the company's prior closing share price.
This landmark financing is designed to significantly boost Perfect Moment's cash flow, support its continued listing requirements, and fund key strategic growth initiatives. These plans include product innovation, expanding into new categories, and even a push into the Chinese market. This news comes on the heels of the company reporting its first profitable quarter, further strengthening investor confidence in its future path.
This analysis was generated using AI and real-time stock data. Always do your own research before making investment decisions.